|
|
|
|
Litigation Over Johnson & Johnson Antibiotic Levaquin Designated N.J. Mass Tort
The New Jersey Supreme Court has designated mounting litigation over the antibiotic Levaquin as a mass tort and has assigned it to an Atlantic County, N.J., judge.The suits charge that the drug, which is prescribed for...
|
|
|
Bangladesh Drug-maker To Enter Malaysia
NEW DELHI, June 3 (Bernama) -- A major Bangladesh drug-maker Renata Ltd, is readying itself to enter the Malaysian market with generic drugs, as part of a global expansion plan.'We are looking at Asean as a whole and...
|
|
|
J&J buys GBP610 million Elan stake
BOSTON (Reuters) - Johnson & Johnson has agreed to pay $1 billion (610 million pounds) for an 18.4 percent stake in Irish drugmaker Elan Corp , and will acquire a major stake in Elan's portfolio of experimental drugs to treat...
|
|
|
J&J buys $1 billion stake in Elan, shares soar
The transaction, announced on Thursday, will, among other things, give J&J a 25 percent interest in a closely watched Alzheimer's drug called bapineuzumab, which Elan is developing in a 50-50 partnership with Wyeth.Wyeth is...
|
|
|
J&J buys $1 billion stake in Elan
The transaction, announced on Thursday, will, among other things, give J&J a 25 percent interest in a closely watched Alzheimer's drug called bapineuzumab, which Elan is developing in a 50-50 partnership with Wyeth.Wyeth is...
|
|
|
J&J buys $1 billion Elan stake
BOSTON (Reuters) - Johnson & Johnson has agreed to pay $1 billion (609 million pounds) for an 18.4 percent stake in Irish drugmaker Elan Corp , and will acquire a major stake in Elan's portfolio of experimental drugs to treat...
|
|
|
J&J buys 610 million Elan stake
Johnson & Johnson has agreed to pay $1 billion (610 million pounds) for an 18.4 percent stake in Irish drugmaker Elan Corp , and will acquire a major stake in Elan's portfolio of experimental drugs to treat Alzheimer's disease.
|
|
|
J&J buys $1 billion stake in Elan
Johnson & Johnson has agreed to pay $1 billion (610 million pounds) for an 18.4 percent stake in Irish drugmaker Elan Corp , and will acquire a major stake in Elan's portfolio of experimental drugs to treat Alzheimer's disease.
|
|
|
UPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU Approval
Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) said Friday the European Commission has given market authorization for its closely-watched diabetes treatment Victoza in the 27 European Union member states.Novo Nordisk will...
|
|
|
UPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU Approval
(Adds detail, analyst and CSO comments.) Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) said Friday the European Commission has given market authorization for its closely-watched diabetes treatment Victoza in the 27 European...
|
|
|
Novo Nordisk's Victoza To Reach Market In A Few Weeks - CSO
STOCKHOLM -(Dow Jones)- Novo Nordisk A/S (NOVO-B.KO) expects its closely- watched diabetes treatment Victoza to reach European customers in the nearest future, Chief Scientific Officer Mads Krogsgaard Thomsen said in an interview.'We are...
|
|
|
Novo Nordisk's Victoza To Reach Market In A Few Weeks - CSO
STOCKHOLM -(Dow Jones)- Novo Nordisk A/S (NOVO-B.KO) expects its closely- watched diabetes treatment Victoza to reach European customers in the nearest future, Chief Scientific Officer Mads Krogsgaard Thomsen said in an interview.'We are...
|
|
|
UPDATE 1-St. Jude Medical gets FDA warning on 2 facilities
* Says letter related to manufacturing practices * Says concerns can be resolved without material impact * Sees no impact on customer orders * Says initiated efforts to address FDA's concerns * Shares down 3 pct July 2 (Reuters) - Medical...
|
|
|
Researchers Find New Actions Of Neurochemicals
Work with tiny worm could point to new treatments for human brain disorders Although the tiny roundworm Caenorhabditis elegans has only 302 neurons in its entire nervous system, studies of this simple animal have significantly advanced...
|
|
|
Consumer Reports 'Best Buy Drug' for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year
According to a new report by Consumer Reports Best Buy Drugs, the generic drug doxazosin is as safe and effective as the widely advertised drug Flomax for treating the symptoms of enlarged prostate, and could save...
|
|
|
Abbott Labs loses $1.7 billion Humira patent lawsuit to Johnson & Johnson [Chicago Tribune]
30--In one of the largest patent verdicts in U.S.history, a federal jury Monday said Abbott Laboratories should pay nearly $1.7 billion in damages to Johnson & Johnson, which claimed the suburban Chicago drug giant used J...
|
|
|
UPDATE 2-FDA denies approval of King, Acura's pain drug
BANGALORE, July 2 (Reuters) - Acura Pharmaceuticals Inc and King Pharmaceuticals Inc ( KG - news - people ) said U.S.health regulators denied approval of their pain drug, Acurox, and raised questions on the potential abuse...
|
|
|
UPDATE 1-FDA denies to approve King, Acura's pain drug
* FDA issues complete response letter to the two cos * Raises questions on the drug's abuse-deterrent properties * Cos believe can address issues without additional trials * Acura shares down 5 pct July 2 (Reuters) - Acura...
|
|
|
Global Prescription Drugs Market to Cross 897 Billion by 2015According to New Report by Global Industry Analys
Global Prescription Drugs (http://www.strategyr.com/Prescription_Drugs_Market_Report.asp) market is projected to cross US$897 billion by 2015.The pharmaceutical industry is also witnessing the effects of the global economic downturn...
|
|
|
Promises Drug Treatment Centers See a Troubling Rise in Opiate Addiction
Addiction Psychiatrist Dr.David Sack recommends an integrated approach to opiateaddiction treatmentto reduce the risk of relapse. (Vocus) July 1, 2009 -- Speculation around the cause of Michael Jackson's death has brought...
|
|
|
UPDATE 1-FDA denies to approve King, Acura's pain drug
* FDA issues complete response letter to the two cos * Raises questions on the drug's abuse-deterrent properties * Cos believe can address issues without additional trials * Acura shares down 5 pct July 2 (Reuters) - Acura...
|
|
|
UPDATE 1-FDA denies to approve King, Acura's pain drug
FDA ISSUES COMPLETE RESPONSE LETTER TO THE TWO COS * Raises questions on the drug's abuse-deterrent properties * Cos believe can address issues without additional trials * Acura shares down 5 pct July 2 (Reuters) - Acura...
|
|
|
UPDATE 5-J&J buys $1 bln Elan stake, gains Alzheimer's R&D
BOSTON, July 2 (Reuters) - Johnson & Johnson has agreed to pay $1 billion for an 18.4 percent stake in Irish drugmaker Elan Corp, and will acquire a major stake in Elan's portfolio of experimental drugs to treat Alzheimer's disease...
|
|
|
UPDATE 1-St. Jude Medical gets FDA warning on 2 facilities
* Says concerns can be resolved without material impact * Sees no impact on customer orders * Says initiated efforts to address FDA's concerns * Shares down 3 pct July 2 (Reuters) - Medical devices maker St.Jude Medical ( STJ - news...
|
|
|
Sepracor Clinical Depressive Disorder Drug Misses Primary Endpoint In Phase II Trials - Quick Facts
PM ET RELATED NEWS TOP MARKET NEWS (RTTNews) - Wednesday, Sepracor Inc.(SEPR: News ) said its Phase II clinical trail to evaluate efficacy and safety of SEP-225289 for treatment of major depressive disorder did not meet...
|
